These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations, HLA-DR types, and metabolic control.
    Author: Kernell A, Ludvigsson J.
    Journal: Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):250-3. PubMed ID: 3856546.
    Abstract:
    Eighty-seven diabetics 8.5-26 years old (mean +/- SD 15.3 +/- 3.9) and 32 healthy non-diabetic controls 8-27 years old (13.9 +/- 4.3) were included in the study. They had had the disease for 2 months to 19 years (5.8-4.0 years). Seventy-two of the diabetic patients were HLA-DR type, 13 patients had DR 3 alone, 25 DR4, 33 DR 3,4 and 1 patient was neither DR 3 nor 4. The mean fluorescein concentration in the vitreous body 3.5-7 mm from the retinal surface at 60 min after intravenous administration of fluorescein was 15.5 +/- 11.9 ng/ml in the diabetics and 7.2 +/- 3.7 ng/ml in the non-diabetic controls (P less than 0.001). The diabetics still in partial remission had an almost normal blood-retinal barrier (BRB; 7.9 +/- 4.8 ng/ml) while about 55% of the diabetics beyond remission had impaired barrier function. Abnormal leakage was found in some patients who had had diabetes for less than 2 years and also before the onset of puberty. The incidence of abnormal leakage increased with increasing age and duration. There was a positive correlation between fluorescein leakage and the blood glucose level at the onset of diabetes (P less than 0.01). There was no statistically significant relationship between specific HLA-DR types and abnormal leakage. A defect BRB was significantly correlated with poor short-term metabolic controls, expressed as glucosuria index during the last week before examination with vitreous fluorophotometry. Prospective studies will show whether abnormal BRB gradually leads to irreversible retinopathy.
    [Abstract] [Full Text] [Related] [New Search]